News Focus
News Focus
Followers 391
Posts 18114
Boards Moderated 1
Alias Born 03/07/2014

Re: powerbattles post# 2271

Monday, 06/07/2021 9:01:33 AM

Monday, June 07, 2021 9:01:33 AM

Post# of 13742
QNTA: STRONG_CLOSE_FRIDAY + INVESTOR_CALL_JUNE_8_TOMORROW !

Lets kick this BACK UP TO I-HUB BREAKOUT and MOST READ BOARD - and get it set for the MedoLife Rx NEW MERGER SR MGT CONFERENCE CALL TOMORROW !!


Quanta, Inc. (QNTA) Basic Due Diligence Package



Medolife Rx was created through the merger of Medolife, a private company founded by Dr. Arthur Mikaelian who has completed all research and the development process and has attained the legal registration to commercialize the Blue Scorpion venom based product under the name of Escozine.

https://medolife.com/

Escozine™ was originally developed and commercialized by Medolife, Corp. in 2007. Until 2007, this natural medicine has only been available in Cuba, where it is known as Escozul. Medolife currently holds the exclusive patent license, (United States patent # 8,097,284 B2) of the bioactive peptide and polarization technology used to make the Polarized Dilute Blue Scorpion Venom. Escozine™, is registered and certified for oncological treatment by the Minister of Health in the Dominican Republic. Escozine™ is currently distributed in six countries (Dominican Republic, Vietnam, Russia, Belarus, Nigeria and Kazakhstan).

Escozine has been used for years to treat humans with cancer in many countries and its positive results are backed by numerous scientific research, pre-clinical and clinical observations that confirm its safety and efficacy.

Medolife has been successfully marketing its Escozine products through direct sales in 40 countries. Medolife has invested over $10 million in R&D in Escozine (for humans) over 10 years and amassed substantial scientific documentation, worldwide of its effectiveness.

CLOSER TO FDA APPROVAL, for its Pre-Investigational New Drug (PIND #150335) filing on its lead drug candidate Escozine® as a COVID-19 therapeutic. May 13th marks 30 days since the application.



QNTA aka MedoLife Rx now = IS GOING TO BE A MONSTER RUNNER HERE FOLKS and I mean a freaking MONSTER !!





NEW COMPANY NAME and NEW TICKER SYMBOL ARE NEXT :)

Posts contain only my amateur opinions, personal views and thoughts. I discuss stocks as a hobby only. Always do one's own due diligence before investing.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today